IRIS PubliCatt

Cicchetti, Americo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.817
NA - Nord America 5.621
AS - Asia 1.326
AF - Africa 104
SA - Sud America 82
OC - Oceania 71
Continente sconosciuto - Info sul continente non disponibili 16
Totale 15.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.492
IT - Italia 3.645
DE - Germania 1.300
SE - Svezia 902
CN - Cina 646
UA - Ucraina 440
FR - Francia 391
IE - Irlanda 283
GB - Regno Unito 227
SG - Singapore 179
FI - Finlandia 138
IN - India 116
TR - Turchia 104
CA - Canada 94
RU - Federazione Russa 91
BE - Belgio 69
AU - Australia 57
PL - Polonia 50
NL - Olanda 48
ES - Italia 46
IR - Iran 46
CH - Svizzera 45
BR - Brasile 43
HK - Hong Kong 31
MY - Malesia 29
CZ - Repubblica Ceca 26
TH - Thailandia 26
ID - Indonesia 25
EG - Egitto 22
NO - Norvegia 20
AT - Austria 18
JP - Giappone 18
KE - Kenya 17
MX - Messico 17
PT - Portogallo 17
ZA - Sudafrica 16
CO - Colombia 15
EU - Europa 15
VN - Vietnam 15
NZ - Nuova Zelanda 14
KR - Corea 13
PK - Pakistan 12
TW - Taiwan 12
AR - Argentina 11
GR - Grecia 9
HN - Honduras 9
PH - Filippine 9
RO - Romania 9
BD - Bangladesh 7
ET - Etiopia 7
SI - Slovenia 7
CI - Costa d'Avorio 6
DZ - Algeria 6
MA - Marocco 6
MD - Moldavia 6
MZ - Mozambico 6
PE - Perù 6
DK - Danimarca 5
HR - Croazia 5
IQ - Iraq 5
BG - Bulgaria 4
IL - Israele 4
LB - Libano 4
BN - Brunei Darussalam 3
CY - Cipro 3
GH - Ghana 3
HU - Ungheria 3
NA - Namibia 3
NG - Nigeria 3
NP - Nepal 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CM - Camerun 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
GE - Georgia 2
JM - Giamaica 2
KW - Kuwait 2
LK - Sri Lanka 2
LT - Lituania 2
MV - Maldive 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
UY - Uruguay 2
VG - Isole Vergini Britanniche 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
BZ - Belize 1
EE - Estonia 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MC - Monaco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MW - Malawi 1
QA - Qatar 1
Totale 15.030
Salva come PNG Salva come JPEG
Città #
Chandler 1.039
Rome 411
Ashburn 395
Milan 359
Ann Arbor 333
Jacksonville 320
Dublin 279
San Mateo 213
Cattolica 161
Nanjing 139
Wilmington 138
Woodbridge 118
Plan 117
Marseille 114
Redwood City 109
New York 107
Dearborn 98
Singapore 94
Boston 87
Houston 87
Beijing 76
Fairfield 76
Lawrence 71
Bremen 70
Mountain View 70
Seattle 69
Boardman 68
Princeton 68
Nanchang 61
Brussels 58
Munich 58
Bologna 56
Moscow 56
Nürnberg 51
Turin 47
Izmir 43
Lancaster 43
Bari 42
Helsinki 38
Torino 37
Florence 35
Shanghai 35
Paris 34
Redmond 32
Augusta 31
Frattamaggiore 30
Hangzhou 30
Naples 28
Shenyang 28
Kuala Lumpur 27
Cambridge 26
Chicago 26
Falls Church 26
Ottawa 26
Palermo 26
Pune 26
Modena 25
Tianjin 25
Trieste 25
Andover 24
Changsha 24
Norwalk 24
Leawood 23
Verona 22
Kunming 21
Padova 21
Moncalieri 20
Trento 20
Bangkok 19
Nutley 19
Pisa 19
Fremont 18
Jiaxing 17
Segrate 17
Enterprise 16
Hebei 16
London 16
Pescara 16
Busto Arsizio 15
Guangzhou 15
Radal 15
Amsterdam 14
Brescia 14
Duncan 14
Los Angeles 14
Nairobi 14
San Diego 14
Warsaw 14
Botucatu 13
Saint Petersburg 13
Taranto 13
Perugia 12
Toronto 12
Vienna 12
Ankara 11
Auckland 11
Brno 11
Frankfurt am Main 11
Napoli 11
Piano Di Sorrento 11
Totale 7.073
Salva come PNG Salva come JPEG
Nome #
I costi socio-sanitari dell’insufficienza renale cronica 574
The AdHopHTA handbook: a handbook of hospital-based Health Technology Assessment (HB-HTA) 555
Return-on-Investment of Workplace Health Promotion programs: New Total Worker Health® strategies in the framework of the “One Health” approach 524
Igiene, Medicina Preventiva, Sanità Pubblica. Seconda Edizione 501
Innovazione organizzativa e ruoli emergenti in sanità 397
L'analisi dei network organizzativinei sistemi sanitari: il caso della rete di emergenza della Regione Lazio 339
Innovazione organizzativa e ruoli emergenti in sanità 260
Measuring organizational performance. A review of the dimensions of hospital performance indicators [Pitch presentation] 233
HTA of alternative methods of pathogen inactivation of fresh frozen plasma 223
Misurare le prestazioni organizzative. Revisione delle dimensioni degli indicatori di performance ospedaliera [Poster] 215
Un innovativo incentivo per aumentare l’aderenza alla vaccinazione antinfluenzale tra gli operatori sanitari: analisi cost-consequence e valutazione di sostenibilità. 202
NutriCatt protocol in the enhanced recovery after surgery (ERAS) program for colorectal surgery: the nutritional support improves clinical and cost-effectiveness outcomes. 201
The ethical assessment in HTA reports: the development and the evolution of the ethics consultation by Institute of Bioethics of the Università Cattolica del Sacro Cuore, Rome (Italy) 169
Economia sanitaria 169
Full HTA di Emicizumab 166
IL RUOLO DELL’HEALTH TECHNOLOGY ASSESSMENT NELLA DEFINIZIONE DEI LIVELLI ESSENZIALI DI ASSISTENZA 165
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 159
How could Ethical, Legal, Social & Organizational issues be further integrated in HTA processes? A proposal of “extended” ELSI logics: justifications and considerations moving from the debate and the experience. 149
Economia sanitaria 147
Copertura vaccinale antinfluenzale e assenteismo per malattia negli Operatori Sanitari di un Policlinico Universitario Italiano 144
Il caso del Policlinico A. Gemelli 139
Flu vaccination and value-based health care: operational solutions to safeguard public health 138
La definizione delle priorità nel processo di HTA. Tra esigenze centrali e regionali 137
Factors associated with health-related quality of life: the role of social relationships among the elderly in an Italian region 136
Health Technology Assessment di ausili assorbenti per l’incontinenza urinaria 132
Lo sviluppo della consulenza etica nei processi di HTA: i dati preliminari dell'esperienza dell'Istituto di Bioetica dell'Università Cattolica del Sacro Cuore (Roma) 131
L'HB-HTA: esperienze, buone pratiche e strumenti del progetto europeo AdHopHTA 131
The “triangular model” applied to drug eluting stents (DES) 130
Hospital contextual factors affecting the use of health technologies: a systematic review [Poster display] 126
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 121
Return on investment (ROI) and development of a workplace disability management program in a hospital—a pilot evaluation study 119
Health Technology Assessment and vaccine: new needs and opportunities? 117
Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia. 117
Il ruolo degli stakeholder nel processo di Health Technology Assessment 116
EXPLORING THE ROLE OF PROFESSIONAL NETWORKS ON THE DIFFUSION OF MEDICAL TECHNOLOGIES: AN EMPIRICAL STUDY ON ROBOTIC SURGERY 114
Prioritization of high-cost new drugs for HCV: making sustainability ethical 113
Organizational Models of Hospital Based HTA: Empirical Evidence from Adhophta European Project 113
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 112
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP) 112
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 112
Balanced Scorecard for performance assessment in healthcare settings: a review of literature 109
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy 105
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 105
Diffusione dei modelli dipartimentali nelle aziende sanitarie italiane 104
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 103
La diffusione del modello dipartimentale nel SSN: un fatto solo formale? 101
Healthcare expenditure on prevention in the spending review era 99
INDIVIDUARE, FINANZIARE E COMUNICARE L’INNOVAZIONE IN SANITÀ: IL RUOLO DELL’HEALTH TECHNOLOGY ASSESSMENT 98
The diffusion and impact of the divisional model in Italian National Health service Hospitals 97
Descrizione degli Indicatori e Fonti dei dati 95
Hta e decision making: proposte e risultati dell’Health policy forum 94
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 93
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals 92
Healthcare Reform, Quality and Safety. Perspectives, Participants and Prospects in 30 countries 91
MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY. 91
Il dipartimento non è di carta 89
Descrizione degli Indicatori e Fonti dei dati 89
L'approccio metodologico 89
Extending influenza vaccination to individuals aged 50–64: A budget impact analysis 87
Linking the Price of Cancer Drug Treatments to Their Clinical Value 87
Assessing social and Economic Impact of Subcutaneous Mabs in Oncology 87
Investigating the generalizability of Economic Evaluations conducted in Italy: a critical review 86
Il punto di vista delle aziende 85
Harmonic study: A cost-effectiveness evaluation of ultrasonically activated shears for total thyroidectomy [Lo studio HARMONIC: Valutazione costo-efficacia dell'uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale] 85
Looking good or doing better? Patterns of decoupling in the implementation of Clinical Directorates 85
Health technology assessment in Italy 84
The use of harmonic scalpel versus knot tying for conventional open thyroidectomy: results of a prospective randomized study 83
Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale 83
Hospital restructuring and physician job satisfaction: An empirical study 81
Unfolding similarity in interphysician networks: the impact of institutional and professional homophily 81
Descrizione degli Indicatori e Fonti dei dati 80
Unfolding similarity in interphysician networks: the Impact of Institutional and Professional Homophily 80
The cost-effectiveness of alternative strategies against HBV in Italy 79
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future 79
Assessing social and economic impact of subcutaneous mAbs in oncology 79
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 77
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy. 77
Valutazione multidimensionale e multidisciplinare del servizio di consegna domiciliare dei presidi medici per stomia e incontinenza 77
Il ruolo delle competenze dei rappresentanti dei cittadini: evidenze dalle associazioni italiane dedite all'advocacy 77
Economic assessment of an anti-HCV screening program in Italy 75
A new decision model for economic evaluation of novel therapies for HCV 75
Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster 75
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 75
The ethical relevance of explainibility for AI-solutions for early diagnosis of dementia 74
GUIDING PRINCIPLES FOR GOOD PRACTICES IN HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT UNITS. 74
Ruolo e Regole degli stakeholder nel processo di HTA. Le Evidenze emerse dall’Health Policy Forum della SIHTA 73
Looking good or doing better? Patterns of decoupling in the implementation of clinical directorates. 73
Dealing with COVID-19 epidemic in Italy: Responses from regional organizational models during the first phase of the epidemic 73
Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing 72
Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study 72
THE HARMONIC STUDY: COST-EFFECTIVENESS EVALUATION OF THE USE OF THE ULTRASONIC SCALPEL IN TOTAL THYROIDECTOMY. 70
Come comunicare e trasferire i risultati delle valutazioni di HTA applicata alle vaccinazioni ai decision makers e agli stakeholders? il progetto dell’ISPOR Rome chapter 69
Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system 69
Lo studio HARMONIC: valutazione costo-efficacia dell’uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale 68
“Farmaci insostenibili” e giustizia intergenerazionale in Sanità 67
"Us and Them": a social network analysis of physicians' professional networks and their attitudes towards EBM 66
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. 66
Physicians' propensity to collaborate and their attitude towards EBM: A cross-sectional study 65
Dynamic analysis of interhospital collaboration and competition: Empirical evidence from an Italian regional health system 65
Economic Assessment of an Anti-HCV Screening Program in Italy 64
Totale 12.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.618 312 75 97 51 122 125 191 54 178 107 161 145
2020/20211.688 133 221 59 150 184 110 134 81 211 94 227 84
2021/20221.993 145 130 56 105 174 79 132 250 113 166 322 321
2022/20233.728 429 431 285 523 248 391 223 332 402 140 221 103
2023/20242.870 145 514 116 238 175 305 205 239 143 212 300 278
2024/202557 57 0 0 0 0 0 0 0 0 0 0 0
Totale 15.294